WHO ICTRP trial
The comparative study about the efficacy and safety of alternative DPP-4…
JPRN-UMIN000003479 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000003479 |
|---|---|
| Public title | The comparative study about the efficacy and safety of alternative DPP-4 (dipeptidyl peptidase-4) inhibitor sitagliptin and the rapid-acting insulin secretagogue (glinide) in patients with type 2 diabetes |
| Scientific title | The comparative study about the efficacy and safety of alternative DPP-4 (dipeptidyl peptidase-4) inhibitor sitagliptin and the rapid-acting insulin secretagogue (glinide) in patients with type 2 diabetes - SINGLE Study |
| Primary sponsor | Mie Chuo Medical Center (Mie Prefecture) |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Type 2 diabetes |
| Interventions | Sitagliptin Mitiglinide or nateglinide |
| Registration date | Apr 18, 2010 |
| Target size | 80 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: